Published in Women's Health Weekly, July 28th, 2005
"The purpose of this study was to assess the efficacy of buccal misoprostol to decrease uterine atony, hemorrhage, and the need for additional uterotonic agents during cesarean delivery. Patients who underwent cesarean delivery were assigned randomly to either 200-mcg misoprostol or placebo placed in the buccal space," scientists in the United States report.
"A dilute intravenous oxytocin infusion was given to all patients at delivery of the placenta. The primary outcome variable was the need for additional uterotonic agents. A total of 352 women received random...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly